Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Andreas Hartmann »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Andrea Eugenio Cavanna < Andreas Hartmann < Andreas Kupsch  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 4.
Ident.Authors (with country if any)Title
000010 (2015) Yulia Worbe [France] ; Stephane Lehericy [France] ; Andreas Hartmann [France]Neuroimaging of tic genesis: Present status and future perspectives.
000163 (2011) Priscilla Van Meerbeeck [France] ; Cécile Behar [France] ; Virginie Czernecki [France] ; Emmanuel Roze [France] ; Emmanuelle Deniau [France] ; Andreas Hartmann [France]Motor tic of the neck: A probable cause of stroke in a child with Gilles de la Tourette syndrome
000302 (2008) Mouna Ben Djebara [France] ; Yulia Worbe [France] ; Michael Schüpbach [France] ; Andreas Hartmann [France]Aripiprazole: A treatment for severe coprolalia in “refractory” Gilles de la Tourette syndrome
000513 (2001) Hélène Turmel [France] ; Andreas Hartmann [France] ; Karine Parain [France] ; Aicha Douhou [France] ; Anu Srinivasan [États-Unis] ; Yves Agid [France] ; Etienne C. Hirsch [France]Caspase‐3 activation in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐treated mice

List of associated KwdEn.i

Nombre de
documents
Descripteur
3Male
2Gilles de la Tourette syndrome
2Humans
2Nervous system diseases
11-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (administration & dosage)
11-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (adverse effects)
1Adult
1Animal
1Animal model
1Animals
1Antipsychotic Agents (therapeutic use)
1Apoptosis
1Apoptosis (drug effects)
1Aripiprazole
1Caspase 3
1Caspases (metabolism)
1Child
1Coprolalia
1Disease Models, Animal
1Dopamine Agents (administration & dosage)
1Dopamine Agents (adverse effects)
1Enzymatic activity
1Immunohistochemistry
1MPP+
1MPTP
1Mice
1Mice, Inbred C57BL
1Mouse
1Neck
1Neck (physiopathology)
1Neurons (drug effects)
1Neurons (enzymology)
1Neurons (pathology)
1Parkinson Disease, Secondary (chemically induced)
1Parkinson disease
1Parkinson's disease
1Pathogenesis
1Piperazines (therapeutic use)
1Quinolones (therapeutic use)
1Stroke
1Stroke (etiology)
1Substantia Nigra (drug effects)
1Substantia Nigra (enzymology)
1Tic
1Tics (complications)
1Tics (pathology)
1Tourette Syndrome (drug therapy)
1Tourette Syndrome (pathology)
1Tourette Syndrome (physiopathology)
1Treatment Outcome
1Tyrosine 3-Monooxygenase (metabolism)
1apoptosis
1aripiprazole
1caspase‐3
1coprolalia

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Andreas Hartmann" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Andreas Hartmann" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Andreas Hartmann
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024